Selinexor, Daratumumab, and Dexamethasone (XDd) for Light-Chain Cardiac Amyloidosis
Clinical trial NCT07743957 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07743957
- Sponsor
- Beijing Anzhen Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-13
- Primary completion
- 2028-02-01
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.